NRx Pharmaceuticals, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 58.96. In total, the insiders bought 36 322 719 and sold 5 571 602 NRXP shares in the last 100 trades.

Insider Power

(Last 100 transactions)
58.96
Buy 36 322 719 Shares
Sell 5 571 602 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 13, 2024 Stock Options (Right to buy) Buy Mcbride Dennis 6 320
Jun 13, 2024 Employee Stock Option Plan (right to Buy) Buy Van Voorhees Seth 162 500
Mar 15, 2024 Employee Stock Option Plan (Right to Buy) Buy Strassberg Ira S 212 500
Dec 28, 2023 Buy Rehnquist Janet 0
Sep 13, 2023 Buy Narido Richard Clavano 0
Aug 30, 2023 Common Stock, par value $0.001 per share Buy Gorovitz Aaron 35 000
Aug 30, 2023 Common Stock, par value $0.001 per share Buy Hurvitz Chaim 70 000
Aug 23, 2023 Common Stock Buy Javitt Jonathan C 100 000
Aug 22, 2023 Common Stock Buy Javitt Jonathan C 200 000
Dec 31, 2022 Buy Javitt Jonathan C 0
Dec 16, 2022 Common Stock, par value $0.001 per share Buy Willard Stephen H 50 000
Dec 16, 2022 Common Stock, par value $0.001 per share Buy Van Voorhees Seth 30 000
Dec 07, 2022 Common Stock, par value $0.001 per share Sell Javitt Jonathan C 400 000
Nov 30, 2022 common stock Sell Javitt Daniel C. 8 441
Nov 29, 2022 common stock Sell Javitt Daniel C. 13 730
Nov 28, 2022 Common Stock, par value $0.001 per share Buy Flynn Patrick John 2 500
Nov 28, 2022 Common Stock, par value $0.001 per share Buy Flynn Patrick John 2 500
Nov 28, 2022 Common Stock, par value $0.001 per share Buy Flynn Patrick John 1 750
Nov 25, 2022 Common Stock, par value $0.001 per share Buy Van Voorhees Seth 7 021
Nov 25, 2022 Common Stock, par value $0.001 per share Buy Van Voorhees Seth 600
Nov 25, 2022 Common Stock, par value $0.001 per share Buy Van Voorhees Seth 8 716
Nov 25, 2022 Common Stock, par value $0.001 per share Buy Van Voorhees Seth 7 021
Nov 25, 2022 Common Stock, par value $0.001 per share Buy Van Voorhees Seth 600
Nov 25, 2022 Common Stock, par value $0.001 per share Buy Van Voorhees Seth 8 716
Nov 18, 2022 Common Stock Buy Hurvitz Chaim 40 408
Click to get the best stock tips daily for free!

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal... NRXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT